TIME TO OPIOID USE AMONG COMMERCIALLY-INSURED PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS

被引：0
|
作者：
Zhao, Y. [1 ]
Chen, S. Y. [2 ]
Boulanger, L. [2 ]
Fraser, K. [2 ]
Wu, N. [2 ]
机构：
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Abt Bio Pharma Solut Inc, Lexington, MA USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72303-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A65 / A65
页数：1
相关论文
共 32 条
  • [1] TIME TO OPIOID USE AMONG COMMERCIALLY-INSURED PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS-A PROPENSITY SCORE APPROACH
    Zhao, Y.
    Wu, N.
    Chen, S. Y.
    Fraser, K.
    Boulanger, L.
    VALUE IN HEALTH, 2010, 13 (07) : A285 - A285
  • [2] Time to Opioid Use among Patients with Diabetic Peripheral Neuropathic Pain Who Initiated Duloxetine Versus Other Treatments
    Zhao, Yang
    Boulanger, Luke
    Wu, Ning
    Fraser, Kimberly
    NEUROLOGY, 2009, 72 (11) : A217 - A217
  • [3] TIME TO OPIOID USE AND HEALTH CARE COSTS AMONG PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHIC PAIN WHO INITIATED DULOXETINE VERSUS OTHER TREATMENTS
    Zhao, Y.
    Chen, S. Y.
    Boulanger, L.
    Fraser, K.
    Wu, N.
    VALUE IN HEALTH, 2009, 12 (07) : A404 - A405
  • [4] DULOXETINE THERAPY AND CHANGES IN OPIOID USE AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS
    Wu, N.
    Zhao, Y.
    Boulanger, L.
    Fraser, K.
    Chen, S. Y.
    VALUE IN HEALTH, 2009, 12 (03) : A107 - A107
  • [5] Predictors of Duloxetine versus Other Treatments among Veterans with Diabetic Peripheral Neuropathic Pain: A Retrospective Study
    Zhao, Yingnan
    Liu, Jinan
    Zhao, Yang
    Thethi, Tina
    Fonseca, Vivian
    Shi, Lizheng
    PAIN PRACTICE, 2012, 12 (05) : 366 - 373
  • [6] CHANGES IN OPIOID USE AND ECONOMIC OUTCOMES AMONG DIABETIC PERIPHERAL NEUROPATHIC PAIN PATIENTS TREATED WITH DULOXETINE
    Boulanger, L.
    Wu, N.
    Chen, S. Y.
    Fraser, K.
    Zhao, Y.
    VALUE IN HEALTH, 2009, 12 (03) : A102 - A102
  • [7] Changes in opioid use and healthcare costs among US patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies
    Zhao, Y.
    Wu, N.
    Chen, S.
    Boulanger, L.
    Police, R. L.
    Fraser, K.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (09) : 2147 - 2156
  • [8] Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured US Adults
    McGinty, Emma E.
    Bicket, Mark C.
    Seewald, Nicholas J.
    Stuart, Elizabeth A.
    Alexander, G. Caleb
    Barry, Colleen L.
    McCourt, Alexander D.
    Rutkow, Lainie
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (05) : 617 - +
  • [9] Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured US Adults Comment
    Katz, Jeffrey
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (10) : W118 - W118
  • [10] Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments
    Chen, S.
    Wu, N.
    Fraser, K.
    Boulanger, L.
    Zhao, Y.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2507 - 2516
1234